Skip to content

Drug interactions

Baricitinib + Deferiprone

Severity: Major

Baricitinib and Deferiprone: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Deferiprone can cause agranulocytosis and neutropenia, and baricitinib also suppresses immune function and can lower blood counts. Together they increase the risk of serious infection.

What this interaction means in plain words

Baricitinib and Deferiprone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Baricitinib belongs to Musculoskeletal; Deferiprone belongs to Miscellaneous.

Evidence level: Low

Why it happens

Additive myelosuppressive and immunosuppressive effects.

What to do

Avoid the combination where possible. If both are needed, monitor absolute neutrophil counts frequently and watch for infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Baricitinib and Deferiprone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Baricitinib with Deferiprone?

MediHelp rates the interaction as major. Baricitinib and Deferiprone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Deferiprone can cause agranulocytosis and neutropenia, and baricitinib also suppresses immune function and can lower blood counts. Together they increase the risk of serious infection.

How serious is the interaction between Baricitinib and Deferiprone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible. If both are needed, monitor absolute neutrophil counts frequently and watch for infection.

What other medicines interact with Baricitinib?

MediHelp also lists interactions of Baricitinib with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Tofacitinib. The full list is on the Baricitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in